The knee cartilage repair market has seen considerable growth due to a variety of factors.
• The knee cartilage repair market has also shown strong growth, with an expected rise from $2.91 billion in 2024 to $3.12 billion in 2025, at a CAGR of 7.2%.
This growth is driven by advancements in surgical techniques, increased clinical research and trials, the rise of personalized medicine, economic factors, healthcare spending, and the globalization of healthcare.
The knee cartilage repair market is expected to maintain its strong growth trajectory in upcoming years.
• The knee cartilage repair market is projected to reach $4.05 billion by 2029, growing at a CAGR of 6.7%.
This growth is driven by advancements in biomechanical research, imaging and diagnostic modalities, increased awareness of post-traumatic osteoarthritis, government funding, and medical device innovations. Key trends include regenerative medicine breakthroughs, the evolution of scaffold-based therapies, tissue engineering solutions, and personalized medicine approaches.
The rise in sports-related injuries is expected to propel the growth of the knee cartilage repair market. With increased sports participation, higher-intensity training, and inadequate injury prevention, knee cartilage repair solutions are increasingly needed. The National Safety Council reported that in 2022, 445,642 injuries involving sports equipment were treated in emergency departments, leading to greater demand for knee cartilage repair technologies.
The knee cartilage repair market covered in this report is segmented –
1) By Device Type: Implants, Osteotomy, Bone Grafts, Arthroscopy, Resurfacing, Arthrodesis, Other Devices
2) By Application: Arthroscopic Chondroplasty, Autologous Chondrocyte Implantation, Cell-Based Cartilage Resurfacing, Osteochondral Grafts Transplantation, Other Applications
3) By End User: Hospitals, Ambulatory Surgical Centers, Orthopedic Clinics
Subsegments:
1) By Implants: Metallic Implants, Polymeric Implants, Ceramic Implants
2) By Osteotomy: High Tibial Osteotomy, Distal Femoral Osteotomy, Other Osteotomies
3) By Bone Grafts: Autografts, Allografts, Synthetic Bone Grafts
4) By Arthroscopy: Diagnostic Arthroscopy, Surgical Arthroscopy
5) By Resurfacing: Partial Knee Resurfacing, Total Knee Resurfacing
6) By Arthrodesis: Patella Arthrodesis, Femoral Arthrodesis, Tibial Arthrodesis
7) By Other Devices: Cartilage Scaffolds, Growth Factors, Stem Cell-Based Devices
Leading firms in the knee cartilage repair market are heavily invested in the innovation of new products like knee cartilage repair implants for a greater competitive advantage. These implants are vital in orthopedic surgeries as they aid the repair and regrowth of damaged knee cartilage. An illustration of this is the March 2024 introduction of the MISHA Knee System by UC Davis Health, a medical facility in the US. This system is a knee cartilage repair implant developed for knee cartilage recovery. The MISHA Knee System is an absorbable device designed to regenerate knee cartilage. The implant triggers the body's natural restorative response, enabling fresh cartilage and bone tissue to develop and merge with the implant progressively.
Major companies operating in the knee cartilage repair market are:
• Stryker Corporation
• B. Braun Melsungen AG
• DePuy Synthes
• Zimmer Biomet Holdings Inc.
• Smith & Nephew plc
• Arthrex Inc.
• Integra LifeSciences
• Bioventus LLC
• MTF Biologics
• MiMedx Group Inc.
• Moximed Inc.
• Vericel Corporation
• Anika Therapeutics Inc.
• SeaSpine Holdings Corporation
• LifeNet Health
• ConforMIS Inc.
• Geistlich Pharma AG
• BioPoly LLC
• Regen Lab SA
• Octane Medical Group Inc.
• Orthocell Limited
• Episurf Medical AB
North America was the largest region in the knee cartilage repair market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the knee cartilage repair market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.